Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients

J. L. Murray*, E. S. Kleinerman, J. E. Cunningham, J. R. Tatom, K. Andrejcio, J. Lepe-Zuniga, L. M. Lamki, M. G. Rosenblum, H. Frost, J. U. Gutterman, I. J. Fidler, I. H. Krakoff

*Corresponding author for this work

Research output: Contribution to journalArticle

98 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences